Zachary Brennan Senior Editor With the rise of the Omicron sister variant BA.2, GlaxoSmithKline and Vir Biotechnology’s crucial monoclonal antibody — one of only two mAbs still being shipped by the US government to states to treat Covid-19 — has finally met its match, and almost half of all US states have now lost access...